WAVE Life Sciences Ltd.
WVE
$8.75
$0.121.39%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -5.19% | -89.04% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -5.19% | -89.04% | |||
| Cost of Revenue | 7.01% | -9.01% | |||
| Gross Profit | -10.57% | -180.42% | |||
| SG&A Expenses | -2.00% | 13.76% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 4.20% | -2.96% | |||
| Operating Income | -5.93% | -316.85% | |||
| Income Before Tax | -7.66% | -260.25% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -7.66% | -260.25% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -7.66% | -260.25% | |||
| EBIT | -5.93% | -316.85% | |||
| EBITDA | -6.06% | -304.95% | |||
| EPS Basic | -6.73% | -259.25% | |||
| Normalized Basic EPS | -6.71% | -259.28% | |||
| EPS Diluted | -6.73% | -268.16% | |||
| Normalized Diluted EPS | -6.71% | -269.93% | |||
| Average Basic Shares Outstanding | 0.90% | 0.64% | |||
| Average Diluted Shares Outstanding | 0.90% | -5.67% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||